BIOMAT Database Logo BIOMAT Database Logo

Peptide backbone modifications on the C-terminal hexapeptide of neurotensin. 2008

Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich Alexander University, D-91052 Erlangen, Germany.

To compare backbone-induced susceptibilities with affinity changes that are caused by side-chain modifications in the respective positions, structure activity relationship studies on a series of NT(8-13) analogues were performed providing valuable insights into the major requirement for neurotensin receptor recognition and activation. The data led us to highly potent NTR1 ligands and the generation of a pharmacophore model that will be helpful for the discovery of therapeutically relevant non-peptidic NTR1 agonists.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009496 Neurotensin A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
D010165 Palladium A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.
March 1995, Journal of medicinal chemistry,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
July 2019, Amino acids,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications.
December 2013, ACS medicinal chemistry letters,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Electrochemically Enabled C-Terminal Peptide Modifications.
January 2021, Methods in molecular biology (Clifton, N.J.),
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Synthesis and biological activities of psi (CH2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.
February 1993, International journal of peptide and protein research,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
September 1994, International journal of peptide and protein research,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Peptide backbone modifications in lanthipeptides.
January 2021, Methods in enzymology,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Peptidomimetics and peptide backbone modifications.
October 2002, Mini reviews in medicinal chemistry,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Solution-structure of a peptide designed to mimic the C-terminal hexapeptide of endothelin.
August 1998, The Journal of pharmacy and pharmacology,
Jürgen Einsiedel, and Harald Hübner, and Maud Hervet, and Steffen Härterich, and Susanne Koschatzky, and Peter Gmeiner
Structure-activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methioninyl residues.
August 1987, Journal of medicinal chemistry,
Copied contents to your clipboard!